Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fortress Biotech Inc FBIO

Alternate Symbol(s):  FBIOP

Healthcare Biotechnology
Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary... see more

Recent & Breaking News (NDAQ:FBIO)

Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight

GlobeNewswire May 30, 2018

Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence

GlobeNewswire May 15, 2018

Mustang Bio Reports First Quarter 2018 Financial Results

GlobeNewswire May 14, 2018

Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

GlobeNewswire May 10, 2018

Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

GlobeNewswire May 3, 2018

Mustang Bio to Present at Biotech Innovations Conference

GlobeNewswire April 4, 2018

Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights

GlobeNewswire March 29, 2018

Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol

GlobeNewswire March 28, 2018

Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis

GlobeNewswire March 27, 2018

Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis

GlobeNewswire March 21, 2018

Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301

GlobeNewswire March 21, 2018

Mustang Bio to Present at CAR-T Congress USA

GlobeNewswire March 19, 2018

Fortress Biotech Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights

GlobeNewswire March 16, 2018

Checkpoint Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights

GlobeNewswire March 15, 2018

Checkpoint Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting

GlobeNewswire March 15, 2018

Mustang Bio Announces Key Leadership Appointments

GlobeNewswire March 15, 2018

Fortress Biotech to Present at Oppenheimer’s 28th Annual Healthcare Conference

GlobeNewswire March 13, 2018

Mustang Bio to Present at March Investor Conferences

GlobeNewswire March 13, 2018

Checkpoint Therapeutics to Participate in March Investor Conferences

GlobeNewswire March 13, 2018

Mustang Bio to Present at the 255th American Chemical Society National Meeting & Exposition

GlobeNewswire March 12, 2018